Skip to main content

Advertisement

Table 1 Clinical parameters for all the groups (mean ± SD), (paired t-test).

From: Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram

   Baseline Endpoint p
OCD (n = 11) YBOCS 26.6 ± 4.7 23.7 ± 5.8 0.001
  MADRS 13.64 ± 9.6 9.9 ± 6.4 0.119
  CGI-severity 4.7 ± 0.647 4.18 ± 1.1 0.025
  CGI-improvement   3.1 ± 0.7  
SAD (n = 15) LSAS 79.2 ± 30.2 63.1 ± 28.5 0.003
  MADRS 15 ± 4.9 9.1 ± 5.9 0.004
  CGI-severity 4.6 ± 0.8 3.3 ± 1.1 0.001
  CGI-improvement   2.7 ± 1.2  
PTSD (n = 11) CAPS 78.1 ± 16.9 45.5 ± 23.9 <0.01
  MADRS 25 ± 6.7 15.9 ± 8.0 <0.01
  CGI -severity 4.5 ± 0.5 2.5 ± 0.7 <0.01
  CGI-improvement   1.9 ± 0.7  
  1. YBOCS, Yale Brow Obsessive-compulsive scale; MADRS, Montgomery Asberg Depression Rating scale; CGI-s, Clinical global impressions severity; CGI-I, Clinical global impressions – improvement; LSAS, Liebowitz Social Anxiety Scale; CAPS, Clinician Administered PTSD scale.